These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37156089)

  • 21. A new diagnostic algorithm for vascular cognitive impairment: the proposed criteria and evaluation of its reliability and validity.
    Zhao QL; Zhou Y; Wang YL; Dong KH; Wang YJ
    Chin Med J (Engl); 2010 Feb; 123(3):311-9. PubMed ID: 20193251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of vascular stiffness in vascular dementia, Alzheimer dementia and cognitive impairment.
    Rabkin SW; Jarvie G
    Blood Press; 2011 Oct; 20(5):274-83. PubMed ID: 21623679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic Review of the Definitions of Vascular Cognitive Impairment, No Dementia in Cohort Studies.
    Harrison SL; Tang EY; Keage HA; Taylor JP; Allan L; Robinson L; Jagger C; Rockwood K; Stephan BC
    Dement Geriatr Cogn Disord; 2016; 42(1-2):69-79. PubMed ID: 27578207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and risk factors of vascular dementia in Thai stroke patients.
    Dharmasaroja PA; Limwongse C; Charernboon T
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104878. PubMed ID: 32417242
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Zhan M; Sun L; Liu J; Zeng Z; Shen W; Li H; Wang Y; Han F; Shi J; Zeng X; Lu X; Zhang Y; Liao X
    Oxid Med Cell Longev; 2021; 2021():8787684. PubMed ID: 34504643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
    Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A
    J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular cognitive impairment and dementia.
    Gorelick PB; Counts SE; Nyenhuis D
    Biochim Biophys Acta; 2016 May; 1862(5):860-8. PubMed ID: 26704177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentations and epidemiology of vascular dementia.
    Smith EE
    Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vascular dementia and vascular cognitive impairment].
    Qian CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):198-200. PubMed ID: 15171562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular cognitive impairment and vascular dementia.
    Rockwood K
    J Neurol Sci; 2002 Nov; 203-204():23-7. PubMed ID: 12417352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.
    Papanastasiou CA; Theochari CA; Zareifopoulos N; Arfaras-Melainis A; Giannakoulas G; Karamitsos TD; Palaiodimos L; Ntaios G; Avgerinos KI; Kapogiannis D; Kokkinidis DG
    J Gen Intern Med; 2021 Oct; 36(10):3122-3135. PubMed ID: 34244959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients.
    Sachdev PS; Brodaty H; Valenzuela MJ; Lorentz L; Looi JC; Wen W; Zagami AS
    Neurology; 2004 Mar; 62(6):912-9. PubMed ID: 15037692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
    Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
    Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E ε4 allele is associated with vascular cognitive impairment no dementia in Chinese population.
    Han Y; Zhou A; Li F; Wang Q; Xu L; Jia J
    J Neurol Sci; 2020 Feb; 409():116606. PubMed ID: 31865187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
    Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
    Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic issues in vascular dementia: studies, designs and approaches.
    Black SE
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S125-30. PubMed ID: 17474183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment.
    Nguyen DH; Cunningham JT; Sumien N
    Geroscience; 2021 Feb; 43(1):159-166. PubMed ID: 32902819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
    Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
    Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.
    Cunningham EL; Todd SA; Passmore P; Bullock R; McGuinness B
    Cochrane Database Syst Rev; 2021 May; 5(5):CD004034. PubMed ID: 34028812
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.